Skip to main content

Author: Customer Service

Reitar Logtech Teams Up with Xianmu Technology, a Leading Force in China Serving 300,000+ Casual Catering Businesses, to Launch Tokenized Smart Supply Chain Ecosystem and Transform Global Food Supply Chain

HONG KONG, Oct. 10, 2025 (GLOBE NEWSWIRE) — Reitar Logtech Holdings Limited (NASDAQ:RITR)(“Reitar” or “The Company”), Asia’s leading integrated Property + Logistics Technology (PLT) solutions platform, announced at the “Reitar Global Food Supply Chain Ecological Seminar”, a strategic partnership with China’s top casual catering supply chain provider, Hangzhou Xianmu Technology Co., Ltd. (“Xianmu”). Xianmu delivers one-stop smart supply chain solutions for the casual catering market, covering more than 120 major cities and benefiting over 300,000 restaurant clients. Its founder, Jiang Tao, along with several co-founders, has previously worked at Alibaba, possessing rich experience in supply chain and digital transformation, leading Xianmu to successfully complete multiple rounds of financing and technological innovation. Through...

Continue reading

Anavex Life Sciences Announces Presentation at the 35th Alzheimer Europe Conference ‘Connecting Science and Communities: The Future of Dementia Care’

Presentation title: “Advancing Alzheimer’s Disease Care: Convenience for Both Patients and Families with Oral Blarcamesine”NEW YORK, Oct. 10, 2025 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer’s disease, Parkinson’s disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders, today announced that Prof. Dr. Timo Grimmer, MD, member of the Anavex Scientific Advisory Board and National Coordinating Investigator for the blarcamesine Phase IIb/III ANAVEX®2-73-AD-004 study gave an oral presentation titled, “Advancing Alzheimer’s Disease Care: Convenience for Both Patients and Families...

Continue reading

FG Nexus to Ring the Nasdaq Closing Bell

Charlotte, NC, Oct. 10, 2025 (GLOBE NEWSWIRE) — FG Nexus (Nasdaq: FGNX, FGNXP) (the “Company” or “FG Nexus”), today announced that the company will ring the Nasdaq closing bell on Monday, October 13, 2025, at 4:00 PM ET. The bell-ringing ceremony will mark a significant milestone for FG Nexus as the company continues its mission to become the largest corporate holder of ETH in the world. “This is a proud moment for our entire team as we celebrate our journey on the Nasdaq and our commitment to delivering long-term shareholder value,” said Kyle Cerminara, CEO of FG Nexus. “Ringing the bell represents our dedication to pioneering Ethereum-powered finance and our role as a strategic gateway into the future of digital assets,” said Maja Vujinovic, CEO of Digital Assets at FG Nexus. The...

Continue reading

Bombardier Set to Impress at NBAA-BACE 2025 with Global and Challenger Jets on Display

Bombardier will participate in NBAA-BACE from October 14–16 in Las Vegas Bombardier Global 7500, Global 6500, and Challenger 3500 aircraft will be featured on static display Media representatives are invited to two exclusive Bombardier events at NBAA-BACE in Las Vegas, including a special unveiling at Henderson Executive Airport on Tuesday, October 14 at 2:00 p.m.MONTREAL, Oct. 10, 2025 (GLOBE NEWSWIRE) — Bombardier announced today its participation in the 2025 edition of the NBAA Business Aviation Convention & Exhibition (NBAA-BACE), taking place October 14–16 at Henderson Executive Airport in Las Vegas. As a global leader in business aviation, Bombardier will showcase three of its most iconic aircraft on static display – the Global 7500, Global 6500, and Challenger 3500 – and will also highlight its top-ranked, comprehensive...

Continue reading

Inspire Medical Systems, Inc. Publishes Inspire V Data at ISSS/AAO-HNS Meetings

MINNEAPOLIS, Oct. 10, 2025 (GLOBE NEWSWIRE) — Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea (OSA), today published Inspire V clinical outcomes data from its Singapore clinical study as well as the Company’s limited market release in the United States including single site experience at two leading centers. These data will be presented at the American Otolaryngology-Head and Neck Surgery (AAO-HNS) and International Surgical Sleep Society (ISSS) meetings being conducted in Indianapolis between October 9 and October 14. “We are incredibly excited to publish first-time clinical evidence on the Inspire V system. The design of the Inspire V system captures experience...

Continue reading

Serve Robotics Announces $100 Million Registered Direct Offering of Common Stock

SAN FRANCISCO, Oct. 10, 2025 (GLOBE NEWSWIRE) — Serve Robotics Inc. (“Serve” or the “Company”) (Nasdaq: SERV), a leading autonomous sidewalk delivery company, announced today that the Company has entered into securities purchase agreements with certain institutional investors for the purchase and sale of 6,250,000 shares of common stock, pursuant to a registered direct offering, expected to result in gross proceeds of approximately $100.0 million, before deducting placement agent fees and other offering expenses. The offering is expected to close on or about October 14, 2025, subject to the satisfaction of customary closing conditions. The Company intends to use net proceeds from the offering for general corporate purposes, including working capital. Northland Capital Markets acted as the sole placement...

Continue reading

Nutriband Signs Agreement With Brand Institute to Develop the Commercial Brand Name for Its Abuse Deterrent Fentanyl Patch

Nutriband initiates commercial worldwide brand name development for its lead product, an abuse deterrent transdermal system. Nutriband has partnered with Brand Institute, Inc, the global leader in pharmaceutical and healthcare-related brand name and identity development. ORLANDO, Fla., Oct. 10, 2025 (GLOBE NEWSWIRE) — Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company engaged in the development of prescription transdermal pharmaceutical products, today announced that through its 4P Therapeutics subsidiary, it has signed an agreement with Brand Institute, Inc, the global leader in pharmaceutical and healthcare-related brand name and identity development services to develop the worldwide commercial brand name and visual identity for its lead product, an abuse deterrent fentanyl transdermal system. This product utilizes Nutriband’s...

Continue reading

Seer Highlights How Proteomics Complements Genomics to Advance Precision Medicine at American Society of Human Genetics (ASHG) 2025

Scientific presentations reveal how Seer’s Proteograph Product Suite is a critical component of multi-omic translational studies and enables profiling of protein isoform-specific biomarkers REDWOOD CITY, Calif., Oct. 10, 2025 (GLOBE NEWSWIRE) — Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced its participation at the upcoming American Society of Human Genetics (ASHG) 2025 Annual Meeting, taking place October 14-18 in Boston. As human genetics research increasingly moves from sequence to function, Seer’s presence at ASHG reflects how proteomics is becoming an essential complement to genomics in understanding disease biology and accelerating precision medicine. Seer will host a featured CoLab session and will be represented in multiple scientific presentations demonstrating...

Continue reading

Draganfly to Showcase Advanced Drone Systems at AUSA 2025

Washington, DC, Oct. 10, 2025 (GLOBE NEWSWIRE) — Draganfly Inc. (NASDAQ: DPRO; CSE: DPRO; FSE: 3U8A) (“Draganfly” or the “Company”), a leader in advanced unmanned systems and integrated drone solutions, today announced its participation at the Association of the U.S. Army (AUSA) Annual Meeting & Exposition from October 13-15, 2025. Draganfly will exhibit in booth (#943) alongside its newest partner, Defense Prime Global Ordnance, where attendees will have the opportunity to experience the Company’s latest drone platforms, sensor systems, and mission-focused technologies firsthand. The AUSA Annual Meeting & Exposition is one of North America’s largest and most influential defense events, bringing together military leaders, government acquisition officials, and global industry partners. The 2025 program will emphasize modernization,...

Continue reading

UCLOUDLINK’s Groundbreaking PetPhone Recognized with Four Awards at IFA 2025; Receives 9 in Total

HONG KONG, Oct. 10, 2025 (GLOBE NEWSWIRE) — UCLOUDLINK GROUP INC. (“UCLOUDLINK” or the “Company”) (NASDAQ: UCL), the world’s first and leading mobile data traffic sharing marketplace, announced that its GlocalMe solutions received a total of nine awards at IFA 2025 in Berlin. The Company’s groundbreaking PetPhone – the world’s first smartphone for pets – earned four as an Honoree in the Communications and Connectivity category of the inaugural IFA Innovation Awards and “Best of IFA 2025” distinctions from Yanko Design, Home Crux, and Mark Ellis Reviews, reflecting third-party recognition of design quality, engineering merit, and consumer impact at the world’s largest consumer and home electronics trade show. PetPhone is a cutting-edge smart device designed to redefine pet care by integrating real-time communication, advanced...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.